Zdrowie i gospodarka · 22/02/2016

FDA Requests Public Comment on Proposed Collection of Information for Drug Labeling Guidance

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to a guidance on drug labeling for cardiovascular outcome claims, which aims to help pharmaceutical companies develop labels for drugs treating hypertension.